Quture–s Health Data Science Technology for Healthcare Providers Unifies Quality & Risk Management and Credentialing Processes in a Value Analytics Market of $24 Billion in 2016 Estimated to Increase to $55 Billion by 2021
DAYTONA BEACH, FL — (Marketwired) — 04/30/15 — (OTCQB: QUTR) ("Quture" or "Q") the proven and experienced clinical performance and outcome analytics and solutions company in health care, today announced filing a provisional patent application (apparatus and method) for its extensive intellectual property (IP).The transformative and disruptive technology claimed in the patent application is for Quture–s complete solution, the QualOptima Connectivity & Analytics Syste
Mr. Guardiola Brings His Investment and Entrepreneurial Expertise, Experience and Industry Connections to Quture-s Vision and Revenue-Based Operations
Quture-s QualOptima Analytics Technology Will Transform the International Capabilities of Therapeutic Solutions to Market and Measure the Performance & Outcomes of Its Devices to Treat Intractable Migraine Headache and Other Conditions
Quture-s Subsidiary for Consulting Services Bundled With Its QualOptima Product Will Support and Strengthen Sales of Software as a Service (SaaS) to Significantly Enhance Revenue
Commercial Sale to Springhill Medical Center of Peer Review & Clinical Performance Analytics Application With Market Potential Exceeding $750 Million Annually
Commercial Sales to Transition From Peer Review to Clinical Performance Analytics Application With Market Potential Exceeding $500 Million Annually
Quture-s Product QualOptima to Become New Standard for Global Performance Enhancement to Transform Payment & Delivery Systems